immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 15 Oct 2019
Application
Utility: Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 10 Oct 2019
Application
Utility: TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 9 Sep 2025 Issue date: 10 Oct 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Immunotherapy against neuronal and brain tumors External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Powerful MHC-class II peptides derived from survivin External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 9 Sep 2025 Issue date: 3 Oct 2019
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 9 Sep 2025 Issue date: 26 Sep 2019
Grant
Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer External link
Filling date: 9 Sep 2025 Issue date: 24 Sep 2019
Grant
Utility: Immunotherapy against neuronal and brain tumors External link
Filling date: 9 Sep 2025 Issue date: 24 Sep 2019
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) External link
Filling date: 9 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 9 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 9 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 5 Sep 2019
Grant
Utility: Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers External link
Filling date: 9 Sep 2025 Issue date: 3 Sep 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 29 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 9 Sep 2025 Issue date: 29 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 27 Aug 2019
Application
Utility: NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME External link
Filling date: 9 Sep 2025 Issue date: 22 Aug 2019
Application
Utility: T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME AGAINST PRAME POSITIVE CANCERS External link
Filling date: 9 Sep 2025 Issue date: 22 Aug 2019
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 22 Aug 2019
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 22 Aug 2019
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 22 Aug 2019
Application
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019

Showing 750 to 800 of 820 patents.